Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis
Hepatitis C virus (HCV) infection is a major cause of viral hepatitis with a global seroprevalence estimated to be greater than 185 million.1 Approximately 75% to 85% of patients with HCV infection develop a chronic hepatitis C (CHC) infection.2 In addition to the direct negative impact of the virus on the liver, where more than 40% of CHC infections lead to liver cirrhosis after 30 years,3 CHC infection is also associated with extrahepatic manifestations including kidney disease, most commonly membranoproliferative glomerulonephritis with or without cryoglobulinemia.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Jonas S öderholm, Charlotta Millbourn, Katharina Büsch, Jan Kövamees, Robert Schvarcz, Karin Lindahl, Annette Bruchfeld Tags: Research Article Source Type: research
More News: Antiviral Therapy | Cirrhosis | Dialysis | Glomerulonephritis | Hemodialysis | Hepatitis | Hepatitis C | Liver | Urology & Nephrology